呼吸系統疾病檢測市場：按檢測類型、最終用戶和地區分類

Respiratory Disease Testing Market, By Test Type, By End User, and By Region

出版日期: 2026年03月12日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，呼吸系統疾病檢測市場規模將達到 36.426 億美元，到 2033 年將達到 48.583 億美元。預計從 2026 年到 2033 年，該市場將以 4.2% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	36.426億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.20%	2033年市場規模預測：	48.583億美元

呼吸系統診斷是指用於診斷患者呼吸系統疾病和紊亂的醫療產品和技術。呼吸系統診斷之所以有效，是因為它能夠實現疾病的早期診斷。呼吸系統疾病是指影響呼吸相關結構和器官的疾病。根據解剖結構，呼吸系統分為上呼吸道和下呼吸道。上呼吸道包括咽、喉和鼻腔，而下呼吸道包括氣管、肺部和支氣管。呼吸系統疾病，或稱為肺部疾病，包括氣喘、囊腫纖維化、肺氣腫、肺癌、間皮瘤、肺動脈高壓和結核病等。如果不及時治療，肺部疾病會導致健康併發症、嚴重症狀，甚至危及生命。

市場動態

產品發布、核准、收購和併購等發展活動正在推動整體市場成長。例如，2022年11月，印度跨國製藥公司Cipla Limited在世界慢性阻塞性肺病日之際，推出了印度首款攜帶式氣流計技術的攜帶式無線肺計量計Spirofy。該公司希望透過此次發布，革新印度阻塞性氣道疾病（OAD）的診斷方式。預計此類發展將在預測期內促進市場成長。例如，2022年9月，羅氏公司（Roche）——一家專注於腫瘤、免疫、感染疾病、眼科和中樞神經系統疾病藥物，以及體外診斷和組織腫瘤診斷的製藥公司——推出了三款分子聚合酵素鏈鎖反應（PCR）診斷試劑盒，用於同時檢測和區分常見呼吸道病原體。因此，該領域的此類進步預計將推動市場成長。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球呼吸系統疾病檢測市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球呼吸系統疾病檢測市場報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
相關人員可以透過利用全球呼吸系統疾病檢測市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非
- 其他非洲國家

第7章：公司簡介

CareFusion Corporation
Carestream Health, Inc.
COSMED
Futuremed America, Inc.
GE Healthcare
MGC Diagnostics Corporation
ndd Medical Technologies, Inc.
Nihon Kohden Corporation
Perkin Elmer, Inc.
FUJIFILM Healthcare Corporation
Philips Healthcare
Roche Healthcare
Beckton Dickinson and Company
Koninklijke Philips NV
ResMed Inc.
Medtronic
Abbott Diagnostics
Quest Diagnostics

第8章

參考
調查方法

簡介目錄

Product Code: CMI4030

Respiratory Disease Testing Market is estimated to be valued at USD 3,642.6 Mn in 2026 and is expected to reach USD 4,858.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,642.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.20%	2033 Value Projection:	USD 4,858.3 Mn

Respiratory diagnostics are the medical products and technologies that are used to diagnose respiratory diseases and disorders in patients. Respiratory diagnostics is effective as it can diagnose diseases at an early stage. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Based on anatomical features, the respiratory system has been segmented into the upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises the pharynx, larynx, and nasal passages, while the lower respiratory tract includes the trachea, lungs, and bronchi. Respiratory disorders, or lung diseases, are disorders such as asthma, cystic fibrosis, emphysema, lung cancer, mesothelioma, pulmonary hypertension, and tuberculosis. If left untreated, lung disease can produce health complications, problematic symptoms, and life-threatening conditions.

Market Dynamics

Development activities such as product launches, approvals, acquisitions, and mergers, among other, are driving the overall market growth. For instance, in November 2022, Cipla Limited, an multinational pharmaceutical company in India, launched Spirofy, India's pneumotach-based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis in India. Such developments are anticipated to contribute to the market growth over the forecast period. For instance, in September 2022, Roche, manufacturing medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche which also specializes in in vitro diagnostics and tissue-based cancer diagnostics, launched three molecular polymerase chain reaction (PCR) diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. Therefore, such advancements in the segment are expected to fuel segment growth.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global respiratory disease testing market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation, Philips Healthcare,Roche Healthcare, Beckton Dickinson and Company, Koninklijke Philips N.V. ResMed Inc., Medtronic, Abbott Diagnostics, and Quest Diagnostics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global respiratory disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory disease testing.

Market Segmentation

Global Respiratory Disease Testing Market, By Test Type (Revenue, USD Mn, 2021 - 2033)
Imaging Test
Spirometry
Peak Flow Test
Blood Gas Test
Lung Volume Test
Others
Global Respiratory Disease Testing Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Physician Offices
Clinical Laboratories
Global Respiratory Disease Testing Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players Insights
CareFusion Corporation
Carestream Health, Inc.
COSMED, Futuremed America, Inc.
GE Healthcare
MGC Diagnostics Corporation
ndd Medical Technologies, Inc.
Nihon Kohden Corporation
Perkin Elmer, Inc.
FUJIFILM Healthcare Corporation
Philips Healthcare
Roche Healthcare
Beckton Dickinson and Company
Koninklijke Philips N.V. ResMed Inc.
Medtronic
Abbott Diagnostics
Quest Diagnostics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Respiratory disease testing Market, By Test Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Imaging Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Spirometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Peak Flow Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Blood Gas Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lung Volume Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Respiratory disease testing Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Physician Offices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Respiratory disease testing Market, By Region, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
North America
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2021-2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa
  - Rest of Africa

7. Company Profiles

CareFusion Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Carestream Health, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
COSMED
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Futuremed America, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
MGC Diagnostics Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
ndd Medical Technologies, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nihon Kohden Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Perkin Elmer, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Healthcare Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Philips Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Roche Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Beckton Dickinson and Company
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
ResMed Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Medtronic
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott Diagnostics
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Quest Diagnostics
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies